Arms
: Patients with ERAS
In the experimental group (Patients with ERAS), participants will undergo an assessment
of the Enhanced Recovery After Surgery (ERAS) consensus items.
The experimental group will complete all the items on the ERAS forms as far as possible.
All groups will undergo our routine preoperative evaluation for pituitary tumor surgery,
such as cardiopulmonary function, hormone testing, vision and visual field examination,
etc. The care during hospitalization and surgery will be the same as previously for
patients with pituitary tumors, and the post-discharge outpatient follow-up will also be
the same as for patients who have undergone pituitary tumor surgery.
: Patients with Regular
In the control group (Patients with Regular), participants will only complete the routine
items as before.
All groups will undergo our routine preoperative evaluation for pituitary tumor surgery,
such as cardiopulmonary function, hormone testing, vision and visual field examination,
etc. The care during hospitalization and surgery will be the same as previously for
patients with pituitary tumors, and the post-discharge outpatient follow-up will also be
the same as for patients who have undergone pituitary tumor surgery.
Interventions
Diagnostic Test: - Malnutrition Universal Screening Tool
The Malnutrition Universal Screening Tool (MUST) is a commonly used tool for assessing
the nutritional status of adult patients. It is designed to identify early whether a
patient is at risk of malnutrition or is already malnourished, enabling timely
intervention and treatment. MUST includes three main assessment criteria:
Body Mass Index (BMI):
Degree of Weight Loss: This assesses the patient's weight change over the past three
months, with grading based on the extent of weight loss.
Effect of Illness on Dietary Intake: This evaluates the impact of illness on the
patient's dietary intake, with grading based on the reduction in dietary intake.
By combining the grades from these three assessment indicators, a final MUST score is
obtained to determine the patient's nutritional status and level of risk. Based on the
MUST score, patients can be categorized as low risk, medium risk, or high risk for
malnutrition.
Device: - TIB Olfactory Test Device
Olfactory testing is conducted on patients undergoing pituitary tumor surgery via nasal
endoscopy using the TIB Olfactory Test Device (TIBSIT). This testing aims to compare
olfactory (sense of smell) outcomes before and after the surgery. The olfactory tests are
performed preoperatively and then again at the 3-month postoperative mark to assess any
changes or impacts on the sense of smell due to the surgery.
Diagnostic Test: - Apfel Score for Postoperative nausea and vomiting
Nausea and Vomiting Risk Scale: Apfel Score
Risk Factors: Female; Smoking habit; History of postoperative nausea and vomiting or
motion sickness; Use of opioid painkillers post-surgery (Each risk factor scores 1 point;
minimum score is 0; maximum score is 4)
Score Probability of Postoperative Nausea and Vomiting
0 - 10%
1.
- 21%
2.
- 39%
3.
- 61%
4.
- 79%
Diagnostic Test: - The American Society of Anesthesiologists (ASA) Physical Status Classification
ASA I: A normal, healthy patient with no systemic disease. ASA II: A patient with mild
systemic disease. ASA III: A patient with severe systemic disease that limits activity
but is not incapacitating.
ASA IV: A patient with severe systemic disease that is a constant threat to life.
ASA V: A moribund patient not expected to survive without the operation. This project
involves collecting data from adult patients aged 20 to 75 years old who are classified
as ASA I to III grade.
Behavioral: - Short Form-36
The Short Form-36 (SF-36) is a widely used health assessment tool, extensively applied in
both research and clinical practice. It is a concise yet comprehensive questionnaire
designed to evaluate individuals' health status and quality of life. The SF-36 covers
eight different dimensions of health, including physical functioning, bodily pain,
general health, vitality, social functioning, emotional health, mental health, and health
change. Each dimension is assessed through a series of questions that address aspects
such as an individual's capabilities in daily life, symptoms, and emotional states. The
SF-36 allows healthcare professionals and researchers to gain insights into a person's
health and quality of life across these varied aspects. Additionally, SF-36 has undergone
extensive testing and validation, proving to have good reliability and validity.
Behavioral: - World Health Organization Quality of Life questionnaire (WHOQOL-BREF)
The World Health Organization Quality of Life questionnaire (WHOQOL-BREF) is a
health-related quality of life assessment tool developed by the World Health Organization
(WHO). It is designed to evaluate an individual's satisfaction with their life and
overall health status. The WHOQOL-BREF is a condensed version of the original WHOQOL-100
questionnaire, intended to reduce the time required to complete it and enhance its
applicability.
Behavioral: - BDI-II(Beck Depression Inventory-II)
The BDI-II consists of 21 questions that assess the degree of depression by asking
respondents about various depressive symptoms they have experienced. These symptoms
include sadness, insomnia or oversleeping, changes in appetite, self-blame, self-disdain,
loss of interest in daily activities, and more. Each question has four possible response
options, allowing respondents to choose the answer that best fits their feelings.
Scoring on the BDI-II ranges from 0 to 63, with higher scores indicating more severe
depression. Based on the scores, the severity of a respondent's depression can be
classified into different levels, ranging from mild to severe. The purpose of using this
scale is to help healthcare professionals assess a patient's depressive symptoms, monitor
changes in condition, and evaluate the effectiveness of treatments.
Behavioral: - ERAS Patient Satisfaction Questionnaire(ERAS-PSQ)
The ERAS Patient Satisfaction Questionnaire (ERAS-PSQ) is a satisfaction survey
specifically designed for patients who have undergone treatment following the Enhanced
Recovery After Surgery (ERAS) protocols. This questionnaire aims to evaluate the
patients' satisfaction and experience with the ERAS approach. Typically, it includes
questions about various aspects of their treatment and care, such as pain management, the
recovery process, the quality of nursing care, and communication with the medical team.
The ERAS-PSQ is an important tool for assessing how well the ERAS protocols are received
by patients and for identifying areas for improvement in patient care within the ERAS
framework.
Behavioral: - Quality of Recovery-40(QoR-40)
The Quality of Recovery-40 (QoR-40) is a widely used questionnaire designed to assess the
quality of recovery after surgery. It comprises 40 questions that cover both physical and
psychological aspects of a patient's recovery, such as pain, nausea, anxiety, dietary
habits, and social functioning. The QoR-40 provides a comprehensive view of a patient's
postoperative recovery, encompassing a range of factors crucial to understanding the
effectiveness of surgical procedures and the overall patient experience during the
recovery phase. This tool is instrumental in evaluating and improving post-surgical care
and patient outcomes.
